Funding Rounds
NorthSea Therapeutics Series C (2021, $80M)
NorthSea TherapeuticsInnovative therapeutic drugs to treat inflammatory, metabolic and liver diseases.
Summary
Stage: Series C
Raised Amount: $80.00M
Raised Date: 2021-01-01
Stage: Series C
Raised Amount: $80.00M
Raised Date: 2021-01-01
